These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the idea of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Diseases. Importantly, these receptors had been identified https://carolq357nmf3.wikilowdown.com/user